Q-Line Biotech Limited
Frequently asked questions
What sector does Q-Line Biotech Limited belong to?
Q-Line Biotech Limited operates in the Healthcare sector, specifically the Medical Equipment & Supplies industry, and is listed on the NSE.
What is the P/E ratio of QLINE?
Q-Line Biotech Limited has a price-to-earnings (P/E) ratio of about 30.00. The P/E ratio compares the share price to earnings per share and is most useful when compared with sector peers and the company's own history.
What is the market capitalisation of QLINE?
The market capitalisation of Q-Line Biotech Limited is approximately ₹1,694 Cr.
Is Q-Line Biotech Limited profitable?
For its latest reported financial year, Q-Line Biotech Limited recorded a net profit margin of about 16.37%.
Does QLINE pay a dividend?
Q-Line Biotech Limited does not currently show a dividend yield in our data.
What is the return on equity (ROE) of QLINE?
Q-Line Biotech Limited has a return on equity (ROE) of about 25.90%. ROE measures how much profit a company generates relative to shareholders' equity.
These answers are generated from reported financial data and live market figures, for educational and informational purposes only.